Illumina Body Map 2 (GSE30611)
Name | miRBASE accession |
---|---|
hsa-miR-218-5p
|
MIMAT0000275 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 26.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 24.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 17.0 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.2 | 15.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.5 | 13.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.2 | 13.2 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
1.0 | 12.8 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.3 | 12.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
4.1 | 12.2 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.9 | 12.0 | GO:0015820 | leucine transport(GO:0015820) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 69.0 | GO:0016021 | integral component of membrane(GO:0016021) |
0.3 | 38.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 32.2 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 26.0 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.4 | 21.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 21.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 19.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 19.3 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 18.6 | GO:0098793 | presynapse(GO:0098793) |
0.0 | 16.6 | GO:0030424 | axon(GO:0030424) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 34.0 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 20.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.5 | 16.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 15.8 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 14.1 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 13.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.5 | 13.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 12.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 12.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 12.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 17.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 12.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 11.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 8.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 7.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 6.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 6.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 5.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 4.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 4.2 | PID REELIN PATHWAY | Reelin signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 32.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.4 | 20.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.4 | 15.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.3 | 15.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 15.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.3 | 14.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.3 | 13.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 13.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.2 | 11.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.2 | 11.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |